A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)

Clinical trial NCT04374136 · TERMINATED

Trial details

NCT number: NCT04374136
Sponsor: Alector Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Frontotemporal Dementia

Start date: 2020-07-23
Primary completion: 2025-09-01
Enrollment: 119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.